4//SEC Filing
Saks Samuel R 4
Accession 0001209191-21-014984
CIK 0001377121other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 6:35 PM ET
Size
7.5 KB
Accession
0001209191-21-014984
Insider Transaction Report
Form 4
Saks Samuel R
Chief Development Officer
Transactions
- Award
Common Stock
2021-02-26+12,000→ 14,000 total - Award
Stock Option (right to buy)
2021-02-26+90,000→ 90,000 totalExercise: $23.57Exp: 2031-02-25→ Common Stock (90,000 underlying)
Footnotes (3)
- [F1]Represents grant of restricted stock units payable solely in common stock that will become fully vested on February 26, 2024.
- [F2]Includes 2,000 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2020.
- [F3]The stock option vests in 48 equal monthly installments following the date of grant.
Documents
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001365615
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 6:35 PM ET
- Size
- 7.5 KB